171 related articles for article (PubMed ID: 36549962)
1. Letter to the editor: "Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study".
Bulloch MN
J Crit Care; 2023 Apr; 74():154239. PubMed ID: 36549962
[No Abstract] [Full Text] [Related]
2. Letter to the editor: "Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study".
Chan WS; Chiu CT; Yeh YC
J Crit Care; 2023 Feb; 73():154175. PubMed ID: 36368175
[No Abstract] [Full Text] [Related]
3. Author reply: Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study.
Arishi H; AlQahtani S; Sadat M; Arabi YM
J Crit Care; 2023 Feb; 73():154176. PubMed ID: 36266194
[No Abstract] [Full Text] [Related]
4. Author's response: "Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study".
Arishi H; AlQahtani S; Sadat M; Arabi Y
J Crit Care; 2023 Apr; 74():154240. PubMed ID: 36543618
[No Abstract] [Full Text] [Related]
5. Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study.
Arishi H; AlQahtani S; Tamim H; Sadat M; Alenezi FZ; Bin Humaid F; AlWehaibi W; Arabi YM
J Crit Care; 2022 Dec; 72():154121. PubMed ID: 35908329
[TBL] [Abstract][Full Text] [Related]
6. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
[TBL] [Abstract][Full Text] [Related]
7. Vasopressor therapy in critically ill patients with shock.
Russell JA
Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
[TBL] [Abstract][Full Text] [Related]
8. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
Sandifer JP; Jones AE
Ann Emerg Med; 2013 Nov; 62(5):534-535. PubMed ID: 23683544
[No Abstract] [Full Text] [Related]
9. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
Saad AF; Maybauer MO
J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910
[TBL] [Abstract][Full Text] [Related]
10. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
[TBL] [Abstract][Full Text] [Related]
11. Low-dose vasopressin in the treatment of vasodilatory septic shock.
Malay MB; Ashton RC; Landry DW; Townsend RN
J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin in septic shock.
Russell JA
Crit Care Med; 2007 Sep; 35(9 Suppl):S609-15. PubMed ID: 17713417
[No Abstract] [Full Text] [Related]
13. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
Menich BE; Miano TA; Patel GP; Hammond DA
Ann Pharmacother; 2019 Sep; 53(9):877-885. PubMed ID: 30957512
[No Abstract] [Full Text] [Related]
14. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
Haan BJ; Cadiz ML; Natavio AM
Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
[No Abstract] [Full Text] [Related]
15. Vasopressin in septic shock: clinical equipoise mandates a time for restraint.
Russell JA
Crit Care Med; 2003 Nov; 31(11):2707-9. PubMed ID: 14605551
[No Abstract] [Full Text] [Related]
16. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
Bauer SR; Sacha GL; Reddy AJ
Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
[No Abstract] [Full Text] [Related]
17. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
18. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
Carr AC; Shaw GM; Fowler AA; Natarajan R
Crit Care; 2015 Nov; 19():418. PubMed ID: 26612352
[TBL] [Abstract][Full Text] [Related]
19. [Role of vasopressin in septic shock : critical evaluation].
Gradwohl-Matis I; Brunauer A; Dankl D; Dünser M
Anaesthesist; 2014 Jun; 63(6):503-10. PubMed ID: 24838480
[TBL] [Abstract][Full Text] [Related]
20. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]